Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEDIRANIB vs CEFMETAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEDIRANIB vs CEFMETAZOLE: Safety Overview

Metric CEDIRANIB CEFMETAZOLE
Total FAERS Reports 130 144
Deaths Reported 27 30
Death Rate 20.8% 20.8%
Hospitalizations 71 85
Average Patient Age 61.2 yrs 60.8 yrs
% Female Patients 62.3% 50.3%
FDA Approval Date N/A Dec 11, 1989
Marketing Status N/A Discontinued